Accueil>>Lipids>> P450>>Curcumenol

Curcumenol (Synonyms: (+)-Curcumenol)

Catalog No.GC41611

Le curcuménol ((+)-Curcumenol) est un puissant inhibiteur du CYP3A4 avec une IC50 de 12,6 μM, qui est l'un des constituants des plantes du genre médicinal important de Curcuma zedoaria, avec neuroprotection, anti-inflammatoire, antitumoral et activités hépatoprotectrices.

Products are for research use only. Not for human use. We do not sell to patients.

Curcumenol Chemical Structure

Cas No.: 19431-84-6

Taille Prix Stock Qté
1mg
29,00 $US
En stock
5mg
65,00 $US
En stock
10mg
102,00 $US
En stock
25mg
212,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com


Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Curcumenol ((+)-Curcumenol) is a potent CYP3A4 inhibitor with an IC50 of 12.6 μM, which is one of constituents in the plants of medicinally important genus of Curcuma zedoaria, with neuroprotection, anti-inflammatory, anti-tumor and hepatoprotective activities. Curcumenol ((+)-Curcumenol) suppresses Akt-mediated NF-κB activation and p38 MAPK signaling pathway in LPS-stimulated BV-2 microglial cells[1][2].

References:
[1]. Sun DX, et al. Inhibitory effects of curcumenol on human liver cytochrome P450 enzymes. Phytother Res. 2010 Aug;24(8):1213-6.
[2]. Lo JY, et al. Curcumenol isolated from Curcuma zedoaria suppresses Akt-mediated NF-κB activation and p38 MAPK signaling pathway in LPS-stimulated BV-2 microglial cells. Food Funct. 2015 Nov;6(11):3550-9.

Avis

Review for Curcumenol

Average Rating: 5 ★★★★★ (Based on Reviews and 39 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Curcumenol

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.